Oculis Holding AG, a global biopharmaceutical company, has appointed Dr. Sharon Klier, an executive leader with extensive experience in clinical development across early and late-stage programs, regulatory submissions, and approvals, to the role of Chief Development Officer.   Klier will oversee and provide strategic leadership across the clinical development and operations of Oculis’ ophthalmology pipeline. She succeeds Bastian Dehmel, M.D., who recently joined Pathalys Pharma as its Chief Me...